BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10412779)

  • 1. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
    Goto T; Saika H; Takahashi T; Maeda A; Mune M; Yukawa S
    Kidney Int Suppl; 1999 Jul; 71():S213-5. PubMed ID: 10412779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism.
    Shirakawa T; Nakajima K; Shimomura Y; Kobayashi J; Stanhope K; Havel P; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():193-200. PubMed ID: 25239670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
    Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
    Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of plasma lipoprotein lipase, hepatic lipase and GPIHBP1 in the metabolism of remnant lipoproteins and small dense LDL in patients with coronary artery disease.
    Muraba Y; Koga T; Shimomura Y; Ito Y; Hirao Y; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Jan; 476():146-153. PubMed ID: 29174344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride content in remnant lipoproteins is significantly increased after food intake and is associated with plasma lipoprotein lipase.
    Nakajima K; Tokita Y; Sakamaki K; Shimomura Y; Kobayashi J; Kamachi K; Tanaka A; Stanhope KL; Havel PJ; Wang T; Machida T; Murakami M
    Clin Chim Acta; 2017 Feb; 465():45-52. PubMed ID: 27986550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of hepatic lipase in intermediate-density lipoprotein and small, dense low-density lipoprotein formation in hemodialysis patients.
    Oi K; Hirano T; Sakai S; Kawaguchi Y; Hosoya T
    Kidney Int Suppl; 1999 Jul; 71():S227-8. PubMed ID: 10412783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired metabolism of high density lipoprotein in uremic patients.
    Shoji T; Nishizawa Y; Nishitani H; Yamakawa M; Morii H
    Kidney Int; 1992 Jun; 41(6):1653-61. PubMed ID: 1501422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment.
    Homma K; Homma Y; Yamaguchi S; Shiina Y; Wakino S; Hayashi K; Hori S; Itoh H
    Int J Clin Pract; 2012 Apr; 66(4):394-8. PubMed ID: 22420498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship of serum lipoprotein lipase mass with fasting serum apolipoprotein B-48 and remnant-like particle triglycerides in type 2 diabetic patients.
    Kobayashi J; Nakajima K; Nohara A; Kawashiri M; Yagi K; Inazu A; Koizumi J; Yamagishi M; Mabuchi H
    Horm Metab Res; 2007 Aug; 39(8):612-6. PubMed ID: 17712727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein lipase does not increase significantly in the postprandial plasma.
    Ishiyama N; Sakamaki K; Shimomura Y; Kotani K; Tsuzaki K; Sakane N; Miyashita K; Fukamachi I; Kobayashi J; Stanhope KL; Havel PJ; Kamachi K; Tanaka A; Tokita Y; Machida T; Murakami M; Nakajima K
    Clin Chim Acta; 2017 Jan; 464():204-210. PubMed ID: 27908779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
    Nishizawa Y; Shoji T; Emoto M; Kawasaki K; Konishi T; Tabata T; Inoue T; Morii H
    Clin Nephrol; 1995 Apr; 43(4):268-77. PubMed ID: 7606882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of probucol on plasma lipoprotein subfractions and activities of lipoprotein lipase and hepatic triglyceride lipase.
    Homma Y; Moriguchi EH; Sakane H; Ozawa H; Nakamura H; Goto Y
    Atherosclerosis; 1991 Jun; 88(2-3):175-81. PubMed ID: 1892484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orlistat fails to alter postprandial plasma lipid excursions or plasma lipases in normal-weight male volunteers.
    Shepard TY; Jensen DR; Blotner S; Zhi J; Guerciolini R; Pace D; Eckel RH
    Int J Obes Relat Metab Disord; 2000 Feb; 24(2):187-94. PubMed ID: 10702769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine.
    Brenta G; Berg G; Miksztowicz V; Lopez G; Lucero D; Faingold C; Murakami M; Machima T; Nakajima K; Schreier L
    Thyroid; 2016 Mar; 26(3):365-72. PubMed ID: 26839156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma.
    Nakajima K; Machida T; Imamura S; Kawase D; Miyashita K; Fukamachi I; Maeda M; Muraba Y; Koga T; Kobayashi J; Kimura T; Nakajima K; Murakami M
    Clin Chim Acta; 2018 Dec; 487():54-59. PubMed ID: 30218657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein lipase activity is favoured by peritoneal dialysis compared to hemodialysis.
    Mahmood D; Nilsson S; Olivecrona G; Stegmayr B
    Scand J Clin Lab Invest; 2014 Jun; 74(4):296-300. PubMed ID: 24564630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipoproteins, apolipoproteins, lipoprotein lipase, hepatic triglyceride lipase and lecithin cholesterol acyltransferase in patients with nephrotic syndrome].
    Breier C; Lisch HJ; Drexel H; Braunsteiner H
    Schweiz Med Wochenschr; 1983 Jun; 113(25):909-13. PubMed ID: 6612272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic triglyceride lipase and lipoprotein lipase activities in post-heparin plasma of patients with various cancers.
    Masuno H; Shiosaka T; Itoh Y; Onji M; Ohta Y; Okuda H
    Jpn J Cancer Res; 1985 Mar; 76(3):202-7. PubMed ID: 2987072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective deficiency of hepatic triglyceride lipase in uremic patients.
    Mordasini R; Frey F; Flury W; Klose G; Greten H
    N Engl J Med; 1977 Dec; 297(25):1362-6. PubMed ID: 200841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.